+
Site Tour

bRIGHT study 1-year data card

Brief outline of the 1-year data outcomes from the bRIGHT study evaluating the safety and effectiveness of TriClip™ TEER in patients with severe TR in a real-world, post-market setting.

Download

Related Resources

EACTS 2021: Impact of MVR Guidelines

TAVI Summit 2023: AS with HF

Now you've got Navitor.
Future ready.

T-TEER: Transcatheter Tricuspid Valve Repair - cases, tips, and tricks

EuroPCR 2023: Mitral regurgitation

Navitor™: Voice of the Experts Maurizio Taramasso

Navitor™: Voice of the Experts Maurizio Taramasso

SAFETY IS A JOURNEY | X. Freixa & F. Castriota

TRENDING TOPICS

EACTS 2024 - Novel approaches for Valvular and LVAD therapies

Reconsidering current approaches to valve and LVAD therapies

Early outcomes on Epic Max platform

Cleveland clinic (US) experience: Early outcomes and a perspective on porcine vs. bovine

Transfemoral TAVI

Navitor Vision 35 implantation

CONNEXT


HUB
RELATED RESOURCES

PCRLV 2022: bRIGHT 1 year

PCR LV 2021: Navitor™ Live-in-a-box

bRIGHT study

PCRLV 2021: Transcatheter mitral valve replacement

CONNEXT


LIVE
RELATED EVENTS

TAVI Summit - Cardiac imaging

AV VALVES 2023: Morphology

AV VALVES 2023:Decision Making in HF – Mitral

Echo course mitral TEER – procedural approach

You are about to leave my-connext.com

You are now leaving my-connext.com. Abbott is not responsible for any content published on the third-party website you are about to enter. Abbott has not reviewed and does not endorse any information presented on third-party websites.

The content on this website is intended for healthcare professionals in EMEA with applicable health authority product registrations, excepted those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Click OK to confirm you are a healthcare professional to proceed.

OK Decline